ERG–TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin-Reference-Cited by-同舟云学术

ERG–TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin

Published:2011-04-15 Issue:8 Volume:24 Page:1120-1127
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Williamson Sean R,Zhang Shaobo,Yao Jorge L,Huang Jiaoti,Lopez-Beltran Antonio,Shen Steven,Osunkoya Adeboye O,MacLennan Gregory T,Montironi Rodolfo,Cheng Liang

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/modpathol201156.pdf

Reference41 articles.

1. Epstein JI, Algaba F, Allsbrook WC, et al. Acinar adenocarcinoma. In: Eble JN, World Health Organization, International Agency for Research on Cancer (eds). World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. IARC Press: Lyon, 2004, pp 162–192.

2. di Sant'Agnese PA, Egevad L, Epstein JI, et al. Neuroendocrine tumors. In: Eble JN, World Health Organization, International Agency for Research on Cancer (eds). World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. IARC Press: Lyon, 2004, pp 207–208.

3. Andreoiu M, Cheng L . Multifocal prostate cancer: biologic, prognostic, and therapeutic implications. Hum Pathol 2010;41:781–793.

4. Helpap B, Kollermann J, Oehler U . Neuroendocrine differentiation in prostatic carcinomas: histogenesis, biology, clinical relevance, and future therapeutical perspectives. Urol Int 1999;62:133–138.

5. Stein ME, Bernstein Z, Abacioglu U, et al. Small cell (neuroendocrine) carcinoma of the prostate: etiology, diagnosis, prognosis, and therapeutic implications--a retrospective study of 30 patients from the rare cancer network. Am J Med Sci 2008;336:478–488.

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment-related Neuroendocrine Prostate Carcinoma—Diagnostic and Molecular Correlates;Advances in Anatomic Pathology;2024-01-15

2. Clinical Next-Generation Sequencing Panels Reveal Molecular Differences Between Merkel Cell Polyomavirus–Negative Merkel Cell Carcinomas and Neuroendocrine Carcinomas;American Journal of Clinical Pathology;2023-02-22

3. Primary large cell carcinoma of ureter ： a case report and review of the literature;2023-01-18

4. FOXA2 drives lineage plasticity and KIT pathway activation in neuroendocrine prostate cancer;Cancer Cell;2022-11

5. Neoplasms of the Prostate;Holland‐Frei Cancer Medicine;2022-10-21